The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model.
Identifieur interne : 000085 ( PubMed/Checkpoint ); précédent : 000084; suivant : 000086The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model.
Auteurs : Robert J. Damstra [Pays-Bas] ; Anne-Berth Halk [Pays-Bas]Source :
- Journal of vascular surgery. Venous and lymphatic disorders [ 2213-3348 ] ; 2017.
Abstract
Lymphedema is a chronic and progressive condition due to an imbalance between lymphatic filtration and transport capacity. A relative overload of fluid is caused by lymphatic impairment (afterload impairment); an absolute overload is caused by increased filtration (preload raised). Lymphedema can result in considerable disability and loss of quality of life. The Dutch Society of Dermatology organized a task force to create guidelines using the International Classification of Functioning, Disability, and Health. As lymphedema is a chronic condition, a new approach was chosen according to the chronic care model. In the development of the guidelines, the following topics of lymphedema care were proposed: (1) lymphedema detection; (2) clinimetric instruments; and (3) rational treatment modalities. A systematic review of the literature published up to June 2013 was conducted. Statements were based on scientific evidence and experience. The guidelines propose recommendations based on an interdisciplinary approach to lymphedema using a continuum of care from prevention to initial treatment phase, maintenance phase, and follow-up. An integrated treatment program can be conservative or surgical. A therapeutic program depends on stage and origin of lymphedema; International Classification of Functioning, Disability, and Health-based limitations; needs of the patient; ability to perform self-management; and ability to reduce patient-related risk factors, such as overweight and lack of exercise.
DOI: 10.1016/j.jvsv.2017.04.012
PubMed: 28818234
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:28818234Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model.</title><author><name sortKey="Damstra, Robert J" sort="Damstra, Robert J" uniqKey="Damstra R" first="Robert J" last="Damstra">Robert J. Damstra</name><affiliation wicri:level="1"><nlm:affiliation>Dutch Expertise Centre of Lympho-Vascular Medicine, Hospital Nij Smellinghe, Drachten, The Netherlands. Electronic address: r.damstra@nijsmellinghe.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Dutch Expertise Centre of Lympho-Vascular Medicine, Hospital Nij Smellinghe, Drachten</wicri:regionArea><wicri:noRegion>Drachten</wicri:noRegion></affiliation></author><author><name sortKey="Halk, Anne Berth" sort="Halk, Anne Berth" uniqKey="Halk A" first="Anne-Berth" last="Halk">Anne-Berth Halk</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Dermatology, Leiden University Medical Centre (LUMC), Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28818234</idno><idno type="pmid">28818234</idno><idno type="doi">10.1016/j.jvsv.2017.04.012</idno><idno type="wicri:Area/PubMed/Corpus">000043</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000043</idno><idno type="wicri:Area/PubMed/Curation">000043</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000043</idno><idno type="wicri:Area/PubMed/Checkpoint">000043</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000043</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model.</title><author><name sortKey="Damstra, Robert J" sort="Damstra, Robert J" uniqKey="Damstra R" first="Robert J" last="Damstra">Robert J. Damstra</name><affiliation wicri:level="1"><nlm:affiliation>Dutch Expertise Centre of Lympho-Vascular Medicine, Hospital Nij Smellinghe, Drachten, The Netherlands. Electronic address: r.damstra@nijsmellinghe.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Dutch Expertise Centre of Lympho-Vascular Medicine, Hospital Nij Smellinghe, Drachten</wicri:regionArea><wicri:noRegion>Drachten</wicri:noRegion></affiliation></author><author><name sortKey="Halk, Anne Berth" sort="Halk, Anne Berth" uniqKey="Halk A" first="Anne-Berth" last="Halk">Anne-Berth Halk</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Dermatology, Leiden University Medical Centre (LUMC), Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author></analytic><series><title level="j">Journal of vascular surgery. Venous and lymphatic disorders</title><idno type="eISSN">2213-3348</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema is a chronic and progressive condition due to an imbalance between lymphatic filtration and transport capacity. A relative overload of fluid is caused by lymphatic impairment (afterload impairment); an absolute overload is caused by increased filtration (preload raised). Lymphedema can result in considerable disability and loss of quality of life. The Dutch Society of Dermatology organized a task force to create guidelines using the International Classification of Functioning, Disability, and Health. As lymphedema is a chronic condition, a new approach was chosen according to the chronic care model. In the development of the guidelines, the following topics of lymphedema care were proposed: (1) lymphedema detection; (2) clinimetric instruments; and (3) rational treatment modalities. A systematic review of the literature published up to June 2013 was conducted. Statements were based on scientific evidence and experience. The guidelines propose recommendations based on an interdisciplinary approach to lymphedema using a continuum of care from prevention to initial treatment phase, maintenance phase, and follow-up. An integrated treatment program can be conservative or surgical. A therapeutic program depends on stage and origin of lymphedema; International Classification of Functioning, Disability, and Health-based limitations; needs of the patient; ability to perform self-management; and ability to reduce patient-related risk factors, such as overweight and lack of exercise.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28818234</PMID><DateCreated><Year>2017</Year><Month>08</Month><Day>18</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-3348</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of vascular surgery. Venous and lymphatic disorders</Title><ISOAbbreviation>J Vasc Surg Venous Lymphat Disord</ISOAbbreviation></Journal><ArticleTitle>The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model.</ArticleTitle><Pagination><MedlinePgn>756-765</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2213-333X(17)30229-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvsv.2017.04.012</ELocationID><Abstract><AbstractText>Lymphedema is a chronic and progressive condition due to an imbalance between lymphatic filtration and transport capacity. A relative overload of fluid is caused by lymphatic impairment (afterload impairment); an absolute overload is caused by increased filtration (preload raised). Lymphedema can result in considerable disability and loss of quality of life. The Dutch Society of Dermatology organized a task force to create guidelines using the International Classification of Functioning, Disability, and Health. As lymphedema is a chronic condition, a new approach was chosen according to the chronic care model. In the development of the guidelines, the following topics of lymphedema care were proposed: (1) lymphedema detection; (2) clinimetric instruments; and (3) rational treatment modalities. A systematic review of the literature published up to June 2013 was conducted. Statements were based on scientific evidence and experience. The guidelines propose recommendations based on an interdisciplinary approach to lymphedema using a continuum of care from prevention to initial treatment phase, maintenance phase, and follow-up. An integrated treatment program can be conservative or surgical. A therapeutic program depends on stage and origin of lymphedema; International Classification of Functioning, Disability, and Health-based limitations; needs of the patient; ability to perform self-management; and ability to reduce patient-related risk factors, such as overweight and lack of exercise.</AbstractText><CopyrightInformation>Copyright © 2017 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Damstra</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Dutch Expertise Centre of Lympho-Vascular Medicine, Hospital Nij Smellinghe, Drachten, The Netherlands. Electronic address: r.damstra@nijsmellinghe.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halk</LastName><ForeName>Anne-Berth</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dutch Working Group on Lymphedema</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg Venous Lymphat Disord</MedlineTA><NlmUniqueID>101607771</NlmUniqueID></MedlineJournalInfo><InvestigatorList><Investigator ValidYN="Y"><LastName>Damstra</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Halk</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>van den Berg</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Born</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butter</LastName><ForeName>E S F A</ForeName><Initials>ESFA</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dorst</LastName><ForeName>E B L</ForeName><Initials>EBL</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Everdingen</LastName><ForeName>J J E</ForeName><Initials>JJE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feenstra</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gielink</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Haas</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Heide-Schoon</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendrickx</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hidding</LastName><ForeName>J T</ForeName><Initials>JT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Storm van Leeuwen</LastName><ForeName>J B</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nijland</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oskam</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paulusma</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Russell</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rutgers-van Wijlen</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sissingh</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strobbe</LastName><ForeName>L J A</ForeName><Initials>LJA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verhoeff-Braat</LastName><ForeName>C J A</ForeName><Initials>CJA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verwaard</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Vleuten</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voesten</LastName><ForeName>H G J M</ForeName><Initials>HGJM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hartog</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Urgert</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>04</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28818234</ArticleId><ArticleId IdType="pii">S2213-333X(17)30229-9</ArticleId><ArticleId IdType="doi">10.1016/j.jvsv.2017.04.012</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country><region><li>Hollande-Méridionale</li></region><settlement><li>Leyde</li></settlement></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Damstra, Robert J" sort="Damstra, Robert J" uniqKey="Damstra R" first="Robert J" last="Damstra">Robert J. Damstra</name></noRegion><name sortKey="Halk, Anne Berth" sort="Halk, Anne Berth" uniqKey="Halk A" first="Anne-Berth" last="Halk">Anne-Berth Halk</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000085 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000085 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:28818234
|texte= The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:28818234" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |